Skip to main content

Table 1 Comparison of clinical characteristics between L-PLADC and D-PLADC

From: Pneumonic-type lung adenocarcinoma with different ranges exhibiting different clinical, imaging, and pathological characteristics

Characteristic

Patients with L-PLADC (n = 131)

Patients with D-PLADC (n = 117)

p value

Age (years)

   

 Means ± standard deviations

62 ± 9

61 ± 11

0.404a

 Range

35–62

23–84

 

Sex

   

 Male

43/131 (32.8%)

72/117 (61.5%)

< 0.001b

 Female

88/131 (67.2%)

45/117 (38.5%)

 

Smoking

   

 Non-smokers

97/131 (74.0%)

52/117 (44.4%)

< 0.001b

 Smokers

34/131 (26.0%)

65/117 (55.6%)

 

Respiratory symptoms

   

 Fever

7/131 (5.3%)

9/117 (7.7%)

0.452b

 Cough

54/131 (41.2%)

103/117 (88.0%)

< 0.001b

 Sputum

42/131 (32.1%)

77/117 (65.8%)

< 0.001b

 Blood in sputum

13/131 (9.9%)

13/117 (11.1%)

0.761b

 Hemoptysis

8/131 (6.1%)

11/117 (9.4%)

0.330b

 Chest pain

16/131 (12.2%)

13/117 (11.1%)

0.787b

 No symptoms

62/131 (47.3%)

5 /117 (4.3%)

< 0.001b

Laboratory results

   

 Elevation of white blood cell count

13/131 (9.9%)

41/117 (35.0%)

0.003b

 Elevation of C-reactive protein level c

10/32 (31.3%)

66/84 (78.6%)

< 0.001b

  1. L-PLADC, localized pneumonic-type lung adenocarcinoma; D-PLADC, diffuse pneumonic-type lung adenocarcinoma
  2. aTwo independent samples Student’s t test
  3. bChi-squared test
  4. cC-reactive protein level was not assessed in 132 patients who did not undergo this test